Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma's promoter, Ravi Agrawal (Trustee Ravi Agrawal Trust), released a pledge on 2,326,289 equity shares. This reduces the promoter's total pledged holding from 4.61% to 2.75% of the company's share capital, citing excess pledge as the reason.
Jun 19 2026 14:25:43
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ajanta Pharma's promoter, Ravi Agrawal Trust, offloaded 34.50 lakh equity shares, amounting to a 2.76% stake reduction. The shares were sold through an open market transaction on June 9, 2026.
Jun 09 2026 15:41:34
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma's promoter, Aayush Agrawal (Trustee Aayush Agrawal Trust), has pledged 28.55 lakh shares, equating to 2.29% of the company's total share capital. This action was undertaken to secure a new loan.
Jun 09 2026 10:22:41
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma's promoter, Gabs Investments Pvt. Ltd., has created a pledge on 27.70 lakh shares, which is 2.22% of the company's total share capital. The pledge was created to secure a new loan.
Jun 09 2026 10:21:24
Read More